Alprazolam
آلپرازولام
🧠 Nervous SystemBenzodiazepine
Market / country: 🇺🇸 USA
Xanax (US)
🧮 Dose calculator
Generalized anxiety disorder · Regimen source: FDA Xanax · 2.1
- • Adjust every 3–4 days; taper gradually (≤0.5 mg every 3 days). FDA Xanax · 2.1FDA Xanax · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to benzodiazepines; strong CYP3A inhibitors (ketoconazole, itraconazole). FDA Xanax · 4
Formulations
- 0.25 mg tablet — tablet 🇺🇸 USA FDA Xanax · 3
- 0.5 mg tablet — tablet 🇺🇸 USA FDA Xanax · 3
- 1 mg tablet — tablet 🇺🇸 USA FDA Xanax · 3
- 2 mg tablet — tablet 🇺🇸 USA FDA Xanax · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Xanax · 8.1
“Risk Summary Neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see Warnings and Precautions (5.8) and Clinical Considerations) ].”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Xanax · 8.2
“Because of the potential for serious adverse reactions, including sedation and withdrawal symptoms in breastfed infants, advise patients that breastfeeding is not recommended during treatment with XANAX.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Xanax · 8.4
“Safety and effectiveness of XANAX have not been established in pediatric patients.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Xanax · 8.5
“XANAX-treated geriatric patients had higher plasma concentrations of alprazolam (due to reduced clearance) compared to younger adult patients receiving the same doses.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA018276
- DailyMed (FDA label)FDA Xanax
- MedlinePlus (NIH)Alprazolam
- WHO ATC/DDDN05BA12
- Darooyab (Iran)Alprazolam
🇮🇷 Registered in Iran Darooyab · G-1223/Alprazolam
Dosage forms with Iranian generic codes, per Darooyab.
- 00040 · ALPRAZOLAM 0.5MG TAB · قرص آلپرازولام ۰٫۵ میلیگرم
- 01382 · ALPRAZOLAM 1MG TAB · قرص آلپرازولام ۱ میلیگرم
- 52892 · ALPRAZOLAM 2MG TAB · قرص آلپرازول ۲ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Xanax · 3FDA Xanax · 2.1FDA Xanax · 2.3FDA Xanax · 2.2FDA Xanax · 4FDA Xanax · 8.1FDA Xanax · 8.2FDA Xanax · 8.4FDA Xanax · 8.5FDA Xanax · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1223/Alprazolam
- Clinical review⚠ Unverified